Document Detail

IL-21 gene polymorphism is associated with the prognosis of breast cancer in Chinese populations.
MedLine Citation:
PMID:  23288348     Owner:  NLM     Status:  Publisher    
Interleukin (IL)-21, which is secreted by activated CD4(+) T cells and NKT cells, has been found to be able to influence the humoral and cell-mediated immune responses and have potent antitumor activity in animal models. This study was to investigate the impact of genetic polymorphisms in IL-21 on survival of breast cancer. Four TagSNPs of IL-21 (rs12508721C>T, rs907715G>A, rs13143866G>A, rs2221903A>G) were selected and then genotyped in 891 patients with breast cancer in Eastern and Southern Chinese populations. We then examined the associations between these SNPs and overall survival. Potential function of rs12508721C>T and association between this variation and breast cancer prognosis were further studied. Overall, 121 of the patients had died over the followed-up period of 5 years. The IL-21 rs12508721T allele predicted longer five-year survival (HR = 0.347, 95 % CI = 0.187-0.644, P < 0.0001) in the discovery cohort, the independent validation cohort (HR = 0.429, 95 % CI = 0.244-0.755, P = 0.012), and combined group (HR = 0.447, 95 % CI = 0.301-0.667, P < 0.0001). Furthermore, our luciferase assay revealed that rs12508721T variant allele had a higher transcription activity and the RT-PCR and ELISA assay showed that rs12508721 variant genotypes (CT and TT) carriers have more IL-21 expression than CC carriers (P < 0.05). Our present study established a robust association between the functional polymorphism (rs12508721C>T) in IL-21 and prognosis of breast cancer, indicating that this polymorphism may be a potential biomarker for prognosis of breast cancer.
Yonghe You; Jieqiong Deng; Jian Zheng; Min Hu; Na Li; Hongchun Wu; Wei Li; Jiachun Lu; Yifeng Zhou
Related Documents :
19669638 - Treatment of brain metastases in patients with her2+ breast cancer.
24982388 - Prevalence of perfusion defects detected by stress 99mtechnetium sestamibi myocardial p...
24160268 - "would a man smell a rose then throw it away?" jordanian men's perspectives on women's ...
7271428 - Ldh isozymes in transplantable hamster tumours with different histogenesis and differen...
24135268 - Biodegradable self-assembled nanoparticles of poly (d,l-lactide-co-glycolide)/hyaluroni...
20549698 - P53 status influences response to tamoxifen but not to fulvestrant in breast cancer cel...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-4
Journal Detail:
Title:  Breast cancer research and treatment     Volume:  -     ISSN:  1573-7217     ISO Abbreviation:  Breast Cancer Res. Treat.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8111104     Medline TA:  Breast Cancer Res Treat     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Laboratory of Cancer Molecular Genetics, Medical College of Soochow University, Suzhou, 215123, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggre...
Next Document:  The changing face of pathogen discovery and surveillance.